Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies.

Bhere, Deepak; Khajuria, Rajiv Kumar; Hendriks, William T; Bandyopadhyay, Antara; Bagci-Onder, Tugba; Shah, Khalid

Bhere, Deepak; Khajuria, Rajiv Kumar; Hendriks, William T; Bandyopadhyay, Antara; Bagci-Onder, Tugba; Shah, Khalid.

Afiliação

Bhere D; Center for Stem Cell Therapeutics and Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Khajuria RK; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hendriks WT; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, India.
Bandyopadhyay A; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bagci-Onder T; Center for Stem Cell Therapeutics and Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Shah K; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Stem Cells ; 36(6): 932-942, 2018 06.

Article em En | MEDLINE | ID: mdl-29451340

Assuntos

Neoplasias Encefálicas/metabolismo; Engenharia Celular/métodos; Reprogramação Celular/fisiologia; Células-Tronco Neurais/fisiologia; Animais; Humanos; Camundongos

Palavras-chave

Brain tumors; Cellular engineering; Epigenetic modulation; Pro-apoptotic therapy; Reprogramming; Stem cells; Targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Reprogramação Celular / Células-Tronco Neurais / Engenharia Celular Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google